BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​

* U.S. FDA ACCEPTS SHIRE'S BIOLOGICS LICENSE APPLICATION FOR CALASPARGASE PEGOL (CAL-PEG) FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)